Skip to content
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
TNC FlipBook Classic items
2023-05-02_PR_Biophytis_strengthens_its_management
By
admin
November 1, 2025
2023-05-02_CP_Renforcement_management
By
admin
November 1, 2025
2023-05-10_Augmentation_de_capital_CP_FR
By
admin
November 1, 2025
2023-05_09_PR_PreSubmission_Meeting_EMA
By
admin
November 1, 2025
2023-05-09_CP_Presubmission_meeting_EMA
By
admin
November 1, 2025
2023-05-15_Depot_Dossier_Phase_3_sarcopenie_CP_FR
By
admin
November 1, 2025
2023-05-11_PR_Succesful_capital_increase_EN
By
admin
November 1, 2025
2023-05-11_CP_Succes-levee-de-fonds_FR
By
admin
November 1, 2025
2023-05-10_FundRaise_PR_EN
By
admin
November 1, 2025
2023-05-25_PR_ATS_2023_EN
By
admin
November 1, 2025
←
1
2
3
4
5
6
7
8
9
10
11
12
…
13
14
15
16
17
…
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
→
Go to Top
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
